/neuro/taxonomy/term/495/all en /neuro/channels/news/breakthrough-ms-treatment-264891 <p><strong>Drug shown to reduce new attacks/symptom progression in some patients</strong></p> <p>In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.</p> Thu, 22 Dec 2016 20:31:26 +0000 shawn.hayward@mcgill.ca 2408 at /neuro